Chika ejikeugwu (43 résultats)

Etat : As New. Unread book in perfect condition.

Etat : New.

Etat : New.

Etat : As New. Unread book in perfect condition.

Etat : As New. Unread book in perfect condition.

Etat : New.

Paperback. Etat : New.

Etat : New. In English.

Etat : New.

Etat : As New. Unread book in perfect condition.

Etat : New. Print on Demand.

Etat : New.

Paperback. Etat : New.

Taschenbuch. Etat : Neu. Antibiogram & Detection of ESBL & MBL in Gram-Negative Bacteria | Chika Ejikeugwu (u. a.) | Taschenbuch | 164 S. | Englisch | 2017 | LAP LAMBERT Academic Publishing | EAN 9783330318892 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.…

Paperback. Etat : Brand New. 164 pages. 8.66x5.91x0.37 inches. In Stock.

paperback. Etat : New. NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Etat : New. Print on Demand.

Taschenbuch. Etat : Neu. Antibiogramme et détection des BLSE et des LBM chez les bactéries à Gram négatif | Chika Ejikeugwu (u. a.) | Taschenbuch | Französisch | 2024 | Editions Notre Savoir | EAN 9786207436538 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.…

Paperback / softback. Etat : New. This item is printed on demand. New copy - Usually dispatched within 5-9 working days.

PAP. Etat : New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

Taschenbuch. Etat : Neu. Antibiogramma e rilevamento di ESBL e MBL nei batteri Gram-negativi | Chika Ejikeugwu (u. a.) | Taschenbuch | Italienisch | 2024 | Edizioni Sapienza | EAN 9786207436552 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu. …

Taschenbuch. Etat : Neu. Antibiograma e deteção de ESBL e MBL em bactérias Gram-negativas | Chika Ejikeugwu (u. a.) | Taschenbuch | Portugiesisch | 2024 | Edições Nosso Conhecimento | EAN 9786207436569 | Verantwortliche Person für die EU: SIA OmniScriptum Publishing, Brivibas Gatve 197, 1039 RIGA, LETTLAND, customerservice[at]vdm-vsg[dot]de | Anbieter: preigu. …

Taschenbuch. Etat : Neu. Antibiogramm & Nachweis von ESBL & MBL bei gramnegativen Bakterien | Chika Ejikeugwu (u. a.) | Taschenbuch | 108 S. | Deutsch | 2024 | Verlag Unser Wissen | EAN 9786207436521 | Verantwortliche Person für die EU: BoD - Books on Demand, In de Tarpen 42, 22848 Norderstedt, info[at]bod[dot]de | Anbieter: preigu. …

PAP. Etat : New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The emergence of new beta-lactamases such as extended spectrum beta-lactamase (ESBL) and metallo beta-lactamase (MBL) is an important mechanism by which pathogenic bacteria develop resistance to beta-lactams. This is of global concern as they are known to make the treatment of bacterial related infections difficult. The objective of this research was to determine phenotypically the occurrence of ESBL and MBL-producing Gram-negative bacteria from clinical isolates. ESBL was detected in 7.5 % Escherichia coli and 33.3 % Klebsiella pneumoniae. None of the P. aeruginosa isolates in our study showed ESBL production by the double disk synergy test (DDST) method. Disk potentiation test detected MBL in 12.5 % E. coli, 15.4 % Klebsiella pneumoniae and 10 % P. aeruginosa isolates while modified Hodges test also detected MBL in 12.5 % Escherichia coli, 7.7 % Klebsiella pneumoniae and 15 % Pseudomonas aeruginosa isolates. Our study reveals that Gram-negative bacteria of clinical origin produce ESBL and MBL. ESBL and MBL detection is crucial as this will help physicians to prescribe the proper therapy for affected patients. Rational use of antibiotics is vital to control resistant microbes. 164 pp. Englisch.…

Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware 104 pp. Spanisch.

Taschenbuch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -The emergence of new beta-lactamases such as extended spectrum ß-lactamase (ESBL) and metallo ß-lactamase (MBL) is an important mechanism by which pathogenic bacteria develop resistance to beta-lactams. This is of global concern as they are known to make the treatment of bacterial related infections difficult. The objective of this research was to determine phenotypically the occurrence of ESBL and MBL-producing Gram-negative bacteria from clinical isolates. ESBL was detected in 7.5 % Escherichia coli and 33.3 % Klebsiella pneumoniae. None of the P. aeruginosa isolates in our study showed ESBL production by the double disk synergy test (DDST) method. Disk potentiation test detected MBL in 12.5 % E. coli, 15.4 % Klebsiella pneumoniae and 10 % P. aeruginosa isolates while modified Hodges test also detected MBL in 12.5 % Escherichia coli, 7.7 % Klebsiella pneumoniae and 15 % Pseudomonas aeruginosa isolates. Our study reveals that Gram-negative bacteria of clinical origin produce ESBL and MBL. ESBL and MBL detection is crucial as this will help physicians to prescribe the proper therapy for affected patients. Rational use of antibiotics is vital to control resistant microbes.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 164 pp. Englisch.…

Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - The emergence of new beta-lactamases such as extended spectrum beta-lactamase (ESBL) and metallo beta-lactamase (MBL) is an important mechanism by which pathogenic bacteria develop resistance to beta-lactams. This is of global concern as they are known to make the treatment of bacterial related infections difficult. The objective of this research was to determine phenotypically the occurrence of ESBL and MBL-producing Gram-negative bacteria from clinical isolates. ESBL was detected in 7.5 % Escherichia coli and 33.3 % Klebsiella pneumoniae. None of the P. aeruginosa isolates in our study showed ESBL production by the double disk synergy test (DDST) method. Disk potentiation test detected MBL in 12.5 % E. coli, 15.4 % Klebsiella pneumoniae and 10 % P. aeruginosa isolates while modified Hodges test also detected MBL in 12.5 % Escherichia coli, 7.7 % Klebsiella pneumoniae and 15 % Pseudomonas aeruginosa isolates. Our study reveals that Gram-negative bacteria of clinical origin produce ESBL and MBL. ESBL and MBL detection is crucial as this will help physicians to prescribe the proper therapy for affected patients. Rational use of antibiotics is vital to control resistant microbes. …

Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware 108 pp. Französisch.

Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - La aparición de nuevas betalactamasas, como la betalactamasa de espectro extendido (ESBL) y la betalactamasa metaloide (MBL), es un mecanismo importante por el que las bacterias patógenas desarrollan resistencia a los betalactámicos. Esto es motivo de preocupación mundial, ya que se sabe que dificultan el tratamiento de las infecciones relacionadas con bacterias. El objetivo de esta investigación era determinar fenotípicamente la presencia de bacterias Gram negativas productoras de ESBL y MBL a partir de aislados clínicos. Se detectaron ESBL en el 7,5% de Escherichia coli y en el 33,3% de Klebsiella pneumoniae. Ninguno de los aislados de P. aeruginosa de nuestro estudio mostró producción de BLEE por el método de la prueba de sinergia de doble disco (DDST). La prueba de potenciación en disco detectó MBL en el 12,5% de los aislados de E. coli, el 15,4% de Klebsiella pneumoniae y el 10% de P. aeruginosa, mientras que la prueba de Hodges modificada también detectó MBL en el 12,5% de los aislados de Escherichia coli, el 7,7% de Klebsiella pneumoniae y el 15% de Pseudomonas aeruginosa. Nuestro estudio revela que las bacterias Gram negativas de origen clínico producen ESBL y MBL. La detección de ESBL y MBL es crucial, ya que ayudará a los médicos a prescribir la terapia adecuada para los pacientes afectados. El uso racional de los antibióticos es vital para controlar los microbios resistentes.…